Gregory M. Hayes

1.7k total citations
37 papers, 1.3k citations indexed

About

Gregory M. Hayes is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Gregory M. Hayes has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Genetics. Recurrent topics in Gregory M. Hayes's work include Chronic Lymphocytic Leukemia Research (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Gregory M. Hayes is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Gregory M. Hayes collaborates with scholars based in United States, United Kingdom and Switzerland. Gregory M. Hayes's co-authors include Laurence J. Miller, Patricia E. Carrigan, Marc K. Hellerstein, Robert Busch, Mohamad Awada, Richard A. Neese, Elizabeth J. Murphy, Nicholas Chiorazzi, R. Kanti and Carlo Calissano and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gastroenterology.

In The Last Decade

Gregory M. Hayes

36 papers receiving 1.3k citations

Peers

Countries citing papers authored by Gregory M. Hayes

Since Specialization

Citations

This map shows the geographic impact of Gregory M. Hayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Hayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Hayes more than expected).

Fields of papers citing papers by Gregory M. Hayes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory M. Hayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Hayes. The network helps show where Gregory M. Hayes may publish in the future.

Co-authorship network of co-authors of Gregory M. Hayes

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory M. Hayes. A scholar is included among the top collaborators of Gregory M. Hayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory M. Hayes. Gregory M. Hayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tolerating bad health research (part 2): still as many bad trials, but more good ones too 2025 ·Trials ·(unknown), Shaun Treweek, Gregory M. Hayes, Frances Shiely	0
2	Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infection 2022 ·Journal of Clinical Virology ·(unknown), (unknown), (unknown), (unknown), Corinne Cayatte, David O. Schmeling, (unknown), Richard C. Brundage, Gregory M. Hayes, Henry H. Balfour	3
3	Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A 2020 ·Molecular Therapy ·Brian Long, P. Véron, Klaudia Kuranda, Romain Hardet, Nina Mitchell, Gregory M. Hayes, Wing Yen Wong, (unknown), Mingjin Li, M. Benjamin Hock, Stephen J. Zoog, Christian Vettermann, Federico Mingozzi, Becky Schweighardt	54
4	DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE 2020 ·Mediterranean Journal of Hematology and Infectious Diseases ·Hui Liu, L Gemmell, Rui Lin, (unknown), Henry H. Balfour, Jennifer Woo, Gregory M. Hayes	5
5	The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy 2019 ·Molecular Therapy — Methods & Clinical Development ·Brian Long, (unknown), Jennifer Holcomb, (unknown), Gregory M. Hayes, (unknown), Carlos Fonck, Laurie Tsuruda, Becky Schweighardt, Charles O’Neill, Stephen J. Zoog, Christian Vettermann	55
6	Adenovirus‐associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus‐associated virus vector–serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A 2019 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), (unknown), Desmond Creagh, Amanda Clark, Gillian Lowe, Nicola Curry, John Pasi, David J. Perry, Sylvia Fong, Gregory M. Hayes, Kandiah Chandrakumaran, Savita Rangarajan	41
7	Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia 2017 ·Leukemia ·Elizabeth J. Murphy, Donna Neuberg, Laura Z. Rassenti, Gregory M. Hayes, Robert Redd, Claire Emson, Chi Kong Li, Jennifer R. Brown, William G. Wierda, Scott Turner, (unknown), Clive S. Zent, John C. Byrd, (unknown), Jacqueline C. Barrientos, Neil E. Kay, Marc K. Hellerstein, Nicholas Chiorazzi, Thomas J. Kipps, (unknown)	26
8	Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo 2015 ·Vaccine ·(unknown), (unknown), Corinne Cayatte, L Gemmell, (unknown), (unknown), Rui Lin, (unknown), Jennifer Woo, Gregory M. Hayes	22
9	IGN523: A Therapeutic Anti-CD98 Antibody With Multiple Mechanisms Of Action Demonstrates Anti-Tumor Efficacy 2013 ·Blood ·Gregory M. Hayes, Lawrence Chinn, Joseph M. Cantor, (unknown), Mark H. Ginsberg, Edward H. van der Horst	4
10	Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells 2011 ·Molecular Medicine ·Carlo Calissano, Rajendra N. Damle, Sonia Marsilio, Xiao‐Jie Yan, Sophia Yancopoulos, Gregory M. Hayes, Claire Emson, Elizabeth J. Murphy, Marc K. Hellerstein, Cristina Sison, Matthew Kaufman, Jonathan E. Kolitz, Steven L. Allen, R. Kanti, (unknown), Igor Dozmorov, Sergio Roa, Matthew D. Scharff, Wentian Li, Nicholas Chiorazzi	129
11	Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: Validation of a simplified method suitable for multi-center clinical studies 2009 ·Leukemia Research ·Gregory M. Hayes, Robert Busch, (unknown), (unknown), (unknown), Marc K. Hellerstein, Nicholas Chiorazzi, R. Kanti, Elizabeth J. Murphy	22
12	Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue 2008 ·Modern Pathology ·Meike Körner, Gregory M. Hayes, Patricia E. Carrigan, Ruth Rehmann, Laurence J. Miller, Jean Claude Reubi	9
13	NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G 2008 ·Leukemia ·Guitta Maki, Gregory M. Hayes, Abderrahim Naji, (unknown), Edgardo D. Carosella, Nathalie Rouas‐Freiss, S. A. Gregory	78
14	A Novel Secretin Receptor Splice Variant Potentially Useful for Early Diagnosis of Pancreatic Carcinoma 2007 ·Gastroenterology ·Gregory M. Hayes, Patricia E. Carrigan, Maoqing Dong, Jean–Claude Reubi, Laurence J. Miller	8
15	Measurement of very low rates of cell proliferation by heavy water labeling of DNA and gas chromatography/pyrolysis/isotope ratio–mass spectrometric analysis 2007 ·Nature Protocols ·(unknown), Mohamad Awada, Elizabeth J. Murphy, Gregory M. Hayes, Robert Busch, Marc K. Hellerstein	35
16	Measurement of cell proliferation by heavy water labeling 2007 ·Nature Protocols ·Robert Busch, Richard A. Neese, Mohamad Awada, Gregory M. Hayes, Marc K. Hellerstein	145
17	Serine-Arginine Protein Kinase 1 Overexpression Is Associated with Tumorigenic Imbalance in Mitogen-Activated Protein Kinase Pathways in Breast, Colonic, and Pancreatic Carcinomas 2007 ·Cancer Research ·Gregory M. Hayes, Patricia E. Carrigan, Laurence J. Miller	140
18	Secretin Receptors in Normal and Diseased Human Pancreas 2005 ·American Journal Of Pathology ·Meike Körner, Gregory M. Hayes, Ruth Rehmann, Arthur Zimmermann, Helmut Frieß, Laurence J. Miller, Jean Claude Reubi	29
19	Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression 2004 ·Cancer Gene Therapy ·Gregory M. Hayes, (unknown), Peter D. Davis, Graeme J. Dougherty	9
20	Identification and Characterization of CD44RC, a Novel Alternatively Spliced Soluble CD44 Isoform that can Potentiate the Hyaluronan Binding Activity of Cell Surface CD44 1999 ·Neoplasia ·Roland K. Chiu, Carmine Carpenito, (unknown), Gregory M. Hayes, Graeme J. Dougherty	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact